FDA grants Beckman Coulter EUA for assay test

2019 08 09 22 20 6739 Beckman Coulter Aacc 2019 400

The U.S. Food and Drug Administration (FDA) has awarded Beckman Coulter emergency use authorization (EUA) for its Access Interleukin-6 (IL-6) assay. The automated immunoassay is designed to detect IL-6 levels in serum and plasma.

The assay can be used to identify a severe inflammatory response and determine the risk of mechanical ventilation intubation in COVID-19 patients. Being able to determine this risk ensures that only patients who really need the ventilator are placed on it.

Page 1 of 147
Next Page